Transrectal Ultrasound of the Prostate (2015)

The Urologist is uniquely qualified by training and experience to perform and interpret transrectal ultrasound of the prostate (TRUS). TRUS performed by the Urologist enhances patient care by providing a minimally invasive procedure that gives real-time information for a rapid and accurate diagnosis. Urologists desire to maintain their high degree of proficiency in performing, interpreting and documenting this imaging study. This video re-enforces the concepts and techniques required to perform high-quality transrectal ultrasound examinations of the prostate.

Target Audience

  • Urologist

Learning Objectives

After completing this activity, the participants should be able to:

  1. Identify the normal transrectal ultrasound appearance of the prostate.
  2. Describe the protocols and technique for transrectal ultrasound of the prostate.
  3. Discuss the common indications for transrectal ultrasound of the prostate.
  4. Appraise the ultrasound appearance of common pathology of the prostate.
  5. Demonstrate the basic transrectal ultrasound examination of the prostate, including documentation and patient safety.
  6. Outline the role of ultrasound imaging during prostate biopsy.
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Course opens: 
05/31/2015
Course expires: 
07/05/2018
Price:
$125.00
Rating: 
0

Faculty

Pat F. Fulgham, MD
Surgical Director of Oncology
Department of Urology
Presbyterian Hospital of Dallas
Dallas, TX
Disclosures: Urology Clinics of North Texas: Other

Bruce R. Gilbert, MD, PhD
Associate Clinical Professor of Urology
Associate Clinical Professor of Reproductive Medicine
Weill Cornell Medical College
Great Neck, NY
Disclosures: Auxillum: Investigator; Bayer Healthcare Pharmaceuticals Inc: Investigator; Warner Chilcott: Investigator

PLANNING COMMITTEE MEMBERS
Urologic Diagnostic & Therapeutic Imaging Committee (UDTIC) Members' Disclosures

Pat F. Fulgham, MD
Dallas, TX
Disclosures: Urology Clinics of North Texas: Other

Ronney Abaza, MD
Columbus, OH
Disclosures: Nothing to disclose

Dean G. Assimos, MD
Winston-Salem, NC
Disclosures: Med Review in Urology: Board Member, Officer, Trustee; National Institute of Health (NIH): Investigator; Oxalosis and Hyperoxaluria Foundation (OHF): Consultant or Advisor; Piedmont Stone: Other; Urology Times: Board Member, Officer, Trustee

Jay T. Bishoff, MD
Salt Lake City, UT
Disclosures: Pfizer: Meeting Participant of Lecturer

Patrick N. Ciccone, MD
Belleville, NJ
Disclosures: Nothing to disclose

Ralph V. Clayman, MD
Irvine, CA
Disclosures: Applied Urology: Investment Interest; Boston Scientific: Other; Cook Urological: Consultant or Advisor; Greenwald Inc: Other; Orthopedic Services Inc (OSI): Other; Vascular Technology Inc: Other

John M. Corman, MD
Seattle, WA
Disclosures: Amgen: Investigator; Astra Zeneca: Investigator; Dendreon: Investigator; Epigenomics: Investigator; Glaxo Smith Kline: Investigator; Roll International: Investigator; Wilex: Investigator

Bruce R. Gilbert, MD, PhD
Great Neck, NY
Disclosures: Auxilium: Investigator; Bayer Healthcare Pharmaceuticals Inc: Investigator; Warner Chilcott: Investigator

Frederick A. Gulmi, MD
Brooklyn, NY
Disclosures: Brooklyn Urologic Research Group: Board Member, Officer, Trustee

Gary M. Kirsh, MD
Loveland, OH
Disclosures: Amgen: Consultant or Advisor; Core Oncology: Consultant or Advisor

Kevin R. Loughlin, MD
Boston, MA
Disclosures: Certus Biomedical: Consultant or Advisor; Predictive Biosciences: Board Member, Officer, Trustee; Sierra Molecular: Consultant or Advisor; Taris: Consultant or Advisor; Tengion: Consultant or Advisor

Peter S. Lund, MD
Erie, PA
Disclosures: Pennsylvania Medical Society: Board Member, Officer, Trustee

Arturo Mendoza-Valdes, MD
Mexico
Disclosures: Bristol Myers: Scientific Study or Trial; Ferring: Scientific Study or Trial;TAKEDA-MILLENIUM: Investigator

Steven M. Schlossberg, MD
New Haven, CT
Disclosures: Nothing to disclose

Richard Scott
Linthicum, MD
Disclosures: Nothing to disclose

Stephanie Stinchcomb, CPC
Linthicum, MD
Disclosures: Accurate Coding Solutions: Consultant or Advisor; Board of Medical Specialty Coding: Consultant or Advisor

Martha K. Terris, MD
Augusta, GA
Disclosures: Nothing to disclose

Edouard J. Trabulsi, MD
Philadelphia, PA
Disclosures: Amgen: Consultant or Advisor; Centocor: Consultant or Advisor; Intuitive Surgical: Consultant or Advisor; Lantheus Medical Imaging: Scientific Study or Trial

Planning Committee Members' Disclosures
Education Council

Elspeth M. McDougall, MD
Orange, CA
Disclosures: Endocare: Other; Ethicon Endo-Surgery: Other; Intuitive Surgical: Other; Karl Storz Endoscopy America: Other; Simbionix: Other

Christopher L. Amling, MD
Portland, OR
Disclosures: Sanofi-Aventis: Meeting Participant or Lecturer

Gopal Badlani, MD
Winston-Salem, NC
Disclosures: Allergan: Investigator; Lithotripsy Group: Piedmont Stone & Physician Discovery: Investment Interest; Olympus: Investigator; Pfizer: Investigator

Peter R. Carroll, MD
San Francisco, CA
Disclosures: Abbott Pharmaceuticals: Investigator; Department of Defense: Investigator; NIH: Investigator

Marc S. Cohen, MD
Gainesville, FL
Disclosures: Nothing to disclose

Robert C. Flanigan, MD
Clarendon Hills, IL
Disclosures: National Cancer Institute: Investigator; NIDDK (NIH): Consultant or Advisor; WJ Weiser: Family/Employee/Affiliation

Pat F. Fulgham, MD
Dallas, TX
Disclosures: Urology Clinics of North Texas: Other

Bruce R. Gilbert, MD, PhD
Greatneck, NY
Disclosures: Auxillum: Investigator; Bayer Healthcare Pharmaceuticals Inc: Investigator; Warner Chilcott: Investigator

David F. Jarrard, MD
Madison, WI
Disclosures: Johnson and Johnson: Consultant or Advisor

David B. Joseph, MD
Birmingham, AL
Disclosures: Center for Disease Control and Prevention: Investigator; Spina Bifida Foundation: Board Member, Officer, Trustee; Tengion: Scientific Study or Trial

Barry A. Kogan, MD
Albany, NY
Disclosures: Nothing to disclose

Benjamin R. Lee, MD
New Orleans, LA
Disclosures: Cook Urological: Consultant or Advisor

Fray F. Marshall, MD
Atlanta, GA
Disclosures: Nothing to disclose

Mary Mathe, PA-C
Celebration, FL
Disclosures: Aureon: Consultant or Advisor

Badar M. Mian, MD
Albany, NY
Disclosures: Nothing to disclose

Arthur P. Mourtzinos, MD
Burlington, MA
Disclosures: Allergan: Investigator; American Medical Systems: Consultant or Advisor; Astellas: Meeting Participant or Lecturer; Coloplast: Meeting Participant or Lecturer; Johnson & Johnson: Consultant or Advisor

J. Kellogg Parsons, MD
LaJolla, CA
Disclosures: AMS: Meeting Participant or Lecturer; Aureon: Consultant or Advisor

Jaspreet S. Sandhu, MD
New York, NY
Disclosures: American Medical Systems: Consultant or Advisor

William D. Steers, MD
Charlottesville, VA
Disclosures: Allergan: Scientific Study or Trial; Food and Drug Administration: Consultant or Advisor; National Institutes of Health: Consultant or Advisor; New England Research Institute (NERI): Consultant or Advisor

John T. Stoffel, MD
Burlington, MA
Disclosures: Nothing to disclose

Chandru P. Sundaram, MD
Indianapolis, IN
Disclosures: Nothing to disclose

Robert M. Sweet, MD
Minneapolis, MN
Disclosures: Allergan: Scientific Study or Trial; American Medical Systems Holding, Inc: Scientific Study or Trial; Coruthers Health Consulting: Consultant or Advisor; Gyrus ACMI Olympus: Other; Medtronic: Scientific Study or Triall; Red Llama Incorporated: Owner

Zhou Wang, PhD
Pittsburgh, PA
Disclosures: Nothing to disclose

Alan J. Wein, MD, PhD
Disclosures: Allergan: Consultant or Advisor; Astellas: Consultant or Advisor; ENDO Pharmaceuticals

Accreditation
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American Urological Association designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AUA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Estimated Time to Complete Activity
2.0 Hours

Medium or Combination of Media Used
Online

Method of Physician Participation and Instructions on Claiming Credits
To claim credits/hours of participation, participants must take the online pretest, view the online video, take the online posttest passing with a score of at least 80%, complete and submit the evaluation.

Target Audience:
urologists, urology residents

AUAER Disclosure Policy
As a provider accredited by the ACCME, the AUAER must ensure balance, independence, objectivity and scientific rigor in all its activities.

All persons in a position to control the content of an educational activity (i.e., activity planners and presenters) provided by the AUAER are required to disclose to the provider any relevant financial relationships they have with any commercial interest. The AUAER must determine if an individual's financial relationships may influence the educational content with regard to exposition or conclusion, and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from serving as planners or presenters, but rather to provide the audience with information on which they can make informed judgments about the material presented.

Disclaimer
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Evidence-Based Content
As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUA to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

Off label or Unapproved Use of Drugs or Devices
It is the policy of the AUAER to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the product prescribing information for full disclosure of approved uses.

Date of Original Release
May 2008

Review Date
This activity was peer reviewed May, 2012 and 2015.

Expiration Date
May 2018

AUA Privacy and Confidentiality Policy
www.auanet.org/cme/onlineeduconf.cfm

Copyright
Materials contained within this video are the sole property of the American Urological Association Education and Research, Inc. and may not be copied or duplicated without the written permission of the American Urological Association Education and Research, Inc.

© 2008, 2011, 2012, 2015 American Urological Association Education and Research, Inc.® All Rights Reserved

Contact Information
For all inquiries regarding CME credit please contact:
Office of Education
American Urological Association
1000 Corporate Blvd.
Linthicum, MD 21090
1-866-RING-AUA (1-866-746-4282)
cme@AUAnet.org

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation

Accreditation Period

Course opens: 
05/31/2015
Course expires: 
07/05/2018

Price

Price:
$125.00
Please login or register to take this course.